Medicamen Biotech Ltd
NSE: MEDICAMEQ BSE: 531146
₹223.30
(-6.49%)
Fri, 03 Apr 2026, 00:27 pm
Market Cap3.05B
PE Ratio31.60
Dividend0.42
Health Technology
Pharmaceuticals: Major
24.5KCompany History
1993
- MBL was incorporated as a public limited company under the Companies Act, 1956.
1994
- The company obtained the certificate of commencement of business.
2010
- The Company has recommended a final dividend of Rs. 0.75 per equity share.
- The Company appointed Mr. B.K.Gupta as Managing Director.
2011
- The Company gets ANVISA.Brazil approval for Non Beta Lactum solid Tablets and Coated tablets manufactured at its Plant situated at SP 1192,A & B, Phase 4, Bhiwadi - 301019, Rajasthan.
2013
- Ms. Harshita Sharma has been appointed as Additional Director of the company.
2016
- Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd.
2019
- FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant.
2020
- Global API Facility started Dahej API Plant.
2021
- Operations started Haridwar formulation Unit II(FDF).
2023
- Medicamen Biotech Gains On Successful Anda Filing For Bortezomib Injections.
2024
- Medicamen Biotech's Bhiwadi Manufacturing Facility Secures EU GMP Approval from Greece.
- Medicamen Biotech's Sterile injectable Facility Received USFDA Approval.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800